Why take this course?
Technical documentation within pharmaceutical, biotechnology, and medical device environments must meet demanding expectations for accuracy, consistency, traceability, and usability. SOPs, validation documents, clinical reports, and regulatory submissions support critical business and compliance activities, yet many organizations face increasing documentation workloads with limited writing resources. As a result, maintaining both quality and efficiency has become a growing operational challenge across regulated environments.
ChatGPT presents new opportunities to improve document development, but its use raises important questions regarding authorship, validation, data integrity, accuracy, and process control. Organizations frequently struggle to determine where AI-assisted writing fits within existing quality systems and documentation workflows. This webinar focuses on practical methods for using ChatGPT as a controlled support tool for drafting, editing, formatting, standardization, and content development. Particular attention is given to maintaining human oversight, validating generated content, preserving traceability, and aligning AI-assisted writing activities with established documentation practices and regulatory expectations.
Key Areas Covered
Charles H. Paul
Charles H. Paul has spent three decades working in regulatory consulting, technical documentation, instructional technology, and training development. His experience includes helping regulated organizations address documentation challenges, develop structured writing processes, and improve training effectiveness. His work with domestic and international clients provides direct relevance to AI-assisted technical writing within controlled documentation environments.
Commonly Asked Questions About This Subject
If ChatGPT helps draft an SOP or validation document, what evidence demonstrates that the organization still owns the content?
Ownership is demonstrated through review decisions, not through document generation. During audits and inspections, reviewers are far more interested in who evaluated, corrected, approved, and accepted the content than who typed the first draft.
Problems emerge when teams adopt AI-generated text with minimal scrutiny. The document may appear professionally written, yet there is little evidence showing how technical accuracy, procedural alignment, or regulatory applicability were verified. Reviewers often discover that comments are superficial, approvals are routine, and no one can explain why specific statements were accepted.
Strong evidence comes from documented review records showing substantive technical assessment. Change histories, reviewer comments, rejected AI suggestions, content revisions, and approval rationale all demonstrate active authorship. These records show that qualified personnel exercised judgment rather than merely accepting generated text.
Inspection friction tends to increase when organizations cannot distinguish between AI-generated content and expert-reviewed content. Once reviewers begin questioning ownership, they frequently expand their examination into training, governance, and document control practices.
Where does AI-assisted technical writing create the greatest regulatory risk even when the final document appears accurate?
The highest risk often appears in statements that sound reasonable but were never verified against internal procedures, validated processes, approved specifications, or current regulatory commitments.
An experienced reviewer may read a document and immediately recognize that the language is polished. The concern arises when supporting evidence cannot be located. A procedure may describe activities that differ slightly from actual practice. A validation protocol may reference acceptance criteria that originated from a previous project. A submission document may contain assumptions that were never approved internally.
These issues frequently survive document reviews because the wording itself does not appear problematic. The error exists in the source of the information rather than the grammar or structure.
Organizations often focus on proofreading AI outputs while giving less attention to factual verification. The documents that become difficult to defend are usually not those with obvious mistakes. They are the ones containing subtle inaccuracies that remain undiscovered until an inspection, investigation, deviation review, or regulatory submission assessment reveals them.
What governance mistake creates the most rework when organizations begin using ChatGPT for technical writing?
Allowing unrestricted use before establishing clear boundaries creates substantial rework later.
Teams often start experimenting independently. One group uses AI for SOP revisions. Another uses it for validation summaries. A third uses it to rewrite investigation reports. Within months, different practices emerge regarding prompting, review expectations, documentation requirements, and approval standards.
The resulting documents may appear consistent on the surface while being produced under entirely different levels of control. Once management attempts to standardize practices, previously issued documents frequently require reassessment because there is no common expectation for review rigor, traceability, or acceptable use.
Governance works best when it defines where AI may be used, where it may not be used, what level of review is required, and how decisions are documented. The objective is not restricting productivity. The objective is ensuring that document quality does not depend on which individual happened to generate the content.
Consistency becomes increasingly important as document volume grows and personnel changes occur.
During an inspection, what questions are likely to be asked if regulators learn that ChatGPT is used in technical writing activities?
Inspectors typically move beyond the software itself and focus on the control system surrounding its use.
The discussion often shifts toward practical questions. Who is authorized to use the tool? How are outputs reviewed? How are factual statements verified? What information is prohibited from being entered? How are procedural inconsistencies identified? What training was provided? How does management know the process is working as intended?
Inspectors generally become concerned when answers rely on trust rather than evidence. Statements such as "our writers know what to check" or "reviewers catch any mistakes" carry little weight without supporting controls.
Evidence that tends to strengthen the discussion includes documented procedures, defined responsibilities, reviewer expectations, training records, periodic assessments, and examples showing how questionable outputs were identified and corrected.
The conversation usually centers on oversight. Once organizations can demonstrate deliberate control, reviewers often spend less time debating the technology itself and more time evaluating whether the established process is being followed consistently.
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Join the Live Training
4. Watch Again Anytime
Testimonials


